IREN
IREN Limited
There isn't enough reported data to score IREN yet.
IX
ORIX Corporation
There isn't enough reported data to score IX yet.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
IX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| N/A | |
| N/A |
IX's profitability is currently strong. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like IX.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
IX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 5.8x | $34.08 | — |
| Cheap | 8.7x | $51.41 | +51% |
| Fair | 11x | $67.56 | +98% |
| Expensive | 14x | $82.03 | +141% |
Historical ranges are pointers, not guarantees.
IX's PE is 5.8x, but its earnings don't support one, so it isn't a reliable read right now.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
IREN has the edge over IX on the outlook, with more favorable revenue and profitability expectations.
IX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect IX's earnings and revenue to decline, with profitability weakening.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
IX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $5.90 | +143% |
| Q1 2026 | $2.49 | +122% |
| Q1 2025 | $1.12 | +203% |
| Q1 2024 | $0.37 | +28% |
| Q4 2023 | $0.30 | -9.1% |
| Q3 2023 | $0.30 | 0% |
| Q1 2023 | $0.29 | -9.4% |
| Q4 2022 | $0.33 | +22% |
IX has the edge over IREN in the latest year-over-year earnings comparison.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
IX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $10.5B | +7% |
| Q1 2026 | $11.1B | +20% |
| Q3 2025 | $9.8B | +11% |
| Q1 2025 | $9.2B | -48% |
| Q3 2024 | $8.8B | +3.2% |
| Q1 2024 | $17.6B | +319% |
| Q4 2023 | $4.3B | +7.6% |
| Q3 2023 | $8.5B | -0.4% |
IX has the edge over IREN in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +0.3 points |
| Q1 2026 | 12% | -0.7 points |
| Q3 2025 | 16% | +1.3 points |
| Q1 2025 | 9.2% | -2.9 points |
| Q3 2024 | 14% | +2.6 points |
| Q1 2024 | 13% | -1.2 points |
| Q4 2023 | 14% | +3.3 points |
| Q3 2023 | 12% | +9 points |
IX has the edge over IREN on profitability, with a higher operating margin.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
IX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.8B | +4.6% |
| Q1 2026 | $4.5B | +9.3% |
| Q3 2025 | $3.6B | +0.5% |
| Q1 2025 | $4.1B | -44% |
| Q3 2024 | $3.6B | +4.1% |
| Q1 2024 | $7.3B | +283% |
| Q4 2023 | $2B | +15% |
| Q3 2023 | $3.5B | +143% |
IX's free cash flow was $16B over the past year, down 2.2% from the year before. Free cash flow isn't a meaningful measure for financial services companies like IX.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
IX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.4% | -27M shares |
| 1 year | -81% | -4.7B shares |
| 3 years | -82% | -4.9B shares |
| 5 years | -83% | -5.3B shares |
| Available history | -83% | -5.4B shares |
IX has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $933.4M |
| Q1 2026 | $490.9M |
| Q3 2025 | $449.3M |
| Q1 2025 | $113.5M |
| Q3 2024 | $222M |
| Q1 2024 | $313.4M |
| Q4 2023 | $116.1M |
| Q3 2023 | $197.3M |
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
IX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q3 2025 | 6.8x | High |
| Q1 2025 | 6.9x | High |
| Q1 2024 | 7.1x | High |
| Q4 2023 | 7.2x | High |
| Q3 2023 | 7.4x | High |
| Q1 2023 | 6.7x | High |
IX's net debt is about 5.7 years of its operating earnings (EBITDA), down from 7.1 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IX.
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
IX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.3 | Neutral |
| Stochastic | 11.3 | Oversold |
IX's weekly RSI is 38 (neutral) and its Stochastic is 11 (oversold).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
IX PE vs Financial Services Sector
| Metric | IX | Sector median | Relative |
|---|---|---|---|
| PE | 5.8x | 13x | 56% below |
| PE % | 5 | 63 | 58 pts below |
IX is trading at 5.8x earnings, a 56% discount to the Financial Services sector's median of 13x, though its earnings don't support one.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
IX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.6 | 6.8% below |
| 20 week MA | $38.4 | 11% below |
| 50 week MA | $35.1 | 2.9% below |
| 100 week MA | $28.9 | 18% above |
| 200 week MA | $24.4 | 40% above |
IX has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
IX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.6 | $14.8 | -11% |
| 2021 | $14.8 | $20.2 | +36% |
| 2022 | $20.2 | $16.3 | -19% |
| 2023 | $16.3 | $18.7 | +15% |
| 2024 | $18.7 | $21.4 | +15% |
| 2025 | $21.4 | $29.4 | +37% |
| 2026 YTD | $29.4 | $34.1 | +16% |
IX has the edge over IREN on returns for 2026, with the stronger performance.